The research team at the FDA’s Office of Prescription Drug Promotion (OPDP) is planning three new studies this year: the effects of product endorsements and implied claims; how descriptions of a drug’s “mechanism of action” affect people’s understanding and impressions of a drug; and how consumers and health care providers make trade-offs in terms of safety and efficacy. In a... Read More